Chronic heart allograft rejection in rats demonstrates a dynamic interplay between IFN-gamma and IL-10 producing T cells

Transplant Immunology
Sadi KöksoyHaval Shirwan

Abstract

The relative roles of different types of T cells and their modes of alloantigen recognition and cytokine production in chronic rejection have been controversial. This may be due to the use of models involving various immune interventions. We recently reported a rat heart allograft model (PVG.1U-to-PVG.R8) that consistently develops chronic rejection without any immune manipulations. Using this model, we investigated the frequency of indirectly activated alloreactive CD4+ T cells and directly/indirectly induced CD8+ T cells and characterized their cytokine profiles at various times posttransplantation. In vitro quantitative-proliferative and intracellular cytokine assays were performed using recipient lymphocytes as responders against donor and third party stimulator cells. Intragraft transcript levels for IFN-gamma were measured using competitive RT-PCR. We observed a steady increase in the frequency of donor reactive CD4+ T cells, peaking on day 18-22 posttransplantation, followed by a decline to background levels on day 60. These cells produced high levels of IL-10 that steadily increased throughout the 100-day experimental period. In contrast, the frequency of donor reactive CD8+ T cells was similar to that of naïve cells an...Continue Reading

References

Dec 1, 1990·The Journal of Experimental Medicine·J A GracieJ A Bradley
Dec 1, 1994·Cellular Immunology·L WangR I Tepper
Mar 1, 1994·The Journal of Experimental Medicine·R S LeeH Auchincloss
Feb 7, 1998·The Journal of Clinical Investigation·R CiubotariuN Suciu-Foca
Nov 12, 1998·The American Journal of Pathology·A Räisänen-SokolowskiM E Russell
Jun 22, 1999·The Journal of Clinical Investigation·A Le MoineD Abramowicz
Dec 14, 1999·The American Journal of Pathology·Y FurukawaR N Mitchell
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·R S LeeJ C Madsen
May 5, 2001·Immunity·P Libby, J S Pober
Aug 14, 2001·Transplant International : Official Journal of the European Society for Organ Transplantation·Q W ZhangH Yasui
May 23, 2002·Transplantation·Alain Le MoineDaniel Abramowicz
Dec 21, 2002·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Akira YamadaHugh Auchincloss
May 20, 2003·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Haval ShirwanSherif Ibrahim

❮ Previous
Next ❯

Citations

Nov 7, 2007·Transplantation·Emilie MamessierMartine Reynaud-Gaubert
Dec 24, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cavit D KantGilles Benichou
Aug 7, 2009·European Journal of Immunology·Ben M IlligensGilles Benichou
Jul 9, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Esma S YolcuHaval Shirwan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.